Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Finn

Showing results (181-190 of 235) with videos related to

Pageof 24
Sort By:
European Journal of Pediatrics|March 6, 2007
Varicella vaccination in Europe: are we ready for a universal childhood programme?Nitu Sengupta, Robert Booy, H J Schmitt, et al.
Molecular Medicine (Cambridge, Mass.)|November 22, 2025
Sensitivity of RSV detection by PCR in respiratory samples is not reduced by a 24 h delay from sampling to testing with storage at room temperatureKatie Lihou, Serena McGuinness, Begonia Morales-Aza, et al.
Viruses|September 23, 2022
Mucin Transiently Sustains Coronavirus Infectivity through Heterogenous Changes in Phase Morphology of Evaporating AerosolRobert W Alexander, Jianghan Tian, Allen E Haddrell, et al.
Life Science Alliance|January 9, 2023
Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19Christopher M Rice, Philip Lewis, Fernando M Ponce-Garcia, et al.
The Pediatric Infectious Disease Journal|September 19, 2025
Quality of Life Impact of Varicella on Children and Their Families in the UK: The QoLPoX StudyRobin Marlow, Marion Roderick, Jenny Oliver, et al.
BMJ Open|July 12, 2018
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of <i>Neisseria meningitidis</i> in adolescentsHelen S Marshall, Mark McMillan, Ann Koehler, et al.
The Lancet. Infectious Diseases|June 26, 2021
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control studyCatherine Hyams, Robin Marlow, Zandile Maseko, et al.
JAMA|February 10, 2012
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trialNicoletta Gossger, Matthew D Snape, Ly-Mee Yu, et al.
BMJ (Clinical Research Ed.)|April 3, 2015
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialDavid Pace, Ameneh Khatami, Jennifer McKenna, et al.
The Lancet Regional Health. Europe|December 19, 2022
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United KingdomCatherine Hyams, Robert Challen, Robin Marlow, et al.
Pageof 24

Showing results (181-190 of 235) with videos related to

Sort By:
Pageof 24
European Journal of Pediatrics|March 6, 2007
Varicella vaccination in Europe: are we ready for a universal childhood programme?Nitu Sengupta, Robert Booy, H J Schmitt, et al.
Molecular Medicine (Cambridge, Mass.)|November 22, 2025
Sensitivity of RSV detection by PCR in respiratory samples is not reduced by a 24 h delay from sampling to testing with storage at room temperatureKatie Lihou, Serena McGuinness, Begonia Morales-Aza, et al.
Viruses|September 23, 2022
Mucin Transiently Sustains Coronavirus Infectivity through Heterogenous Changes in Phase Morphology of Evaporating AerosolRobert W Alexander, Jianghan Tian, Allen E Haddrell, et al.
Life Science Alliance|January 9, 2023
Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19Christopher M Rice, Philip Lewis, Fernando M Ponce-Garcia, et al.
The Pediatric Infectious Disease Journal|September 19, 2025
Quality of Life Impact of Varicella on Children and Their Families in the UK: The QoLPoX StudyRobin Marlow, Marion Roderick, Jenny Oliver, et al.
BMJ Open|July 12, 2018
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of <i>Neisseria meningitidis</i> in adolescentsHelen S Marshall, Mark McMillan, Ann Koehler, et al.
The Lancet. Infectious Diseases|June 26, 2021
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control studyCatherine Hyams, Robin Marlow, Zandile Maseko, et al.
JAMA|February 10, 2012
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trialNicoletta Gossger, Matthew D Snape, Ly-Mee Yu, et al.
BMJ (Clinical Research Ed.)|April 3, 2015
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialDavid Pace, Ameneh Khatami, Jennifer McKenna, et al.
The Lancet Regional Health. Europe|December 19, 2022
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United KingdomCatherine Hyams, Robert Challen, Robin Marlow, et al.
Pageof 24